$OXIS Biotech, Inc. Licenses Worldwide Rights to Cancer Therapy with Positive FDA Phase I Study Results

Oxis Biotech, a wholly-owned subsidiary of Oxis International, Inc. (OTCQB: OXIS) is…

$OXIS Amended Option Agreement Announced

Oxis Biotech Executes Amended Option Agreement With the University of Pittsburgh TAMPA,…

$OXIS Update Provided by @WolfOfWeedST

OXIS has been a topic of conversation as well as a very…

MarijuanaStocks.com to Host $OXIS Conference Call with CEO Tony Cataldo

You asked and we delivered.   Earlier this week, OXIS announced that…

Seeing Into the Future…And Boy Is It Pretty

You know the age old question, “If you had a super power…